CPX Cap-xx Limited

REACH

18 September 2024

CAP-XX Limited

("CAP-XX" or "the Company")

Update re. technology patents

Further to the Company's announcement on 7 May 2024, the Board of CAP-XX Limited, a world leader in the design and manufacture of thin, prismatic supercapacitors and energy management systems, is pleased to confirm that the Company has filed two further provisional patent applications which build upon the filings announced in December 2023. The Company will continue to apply for patents in relation to any new technology which it develops.

For further information contact:

CAP-XX Limited

Pat Elliott (Chairman)                                                                             +61 (2) 9157 0000

Lars Stegmann (Chief Executive Officer)

Allenby Capital (Nominated Adviser and Joint Broker)

David Hart / Piers Shimwell (Corporate Finance)                                      +44 (0) 20 3328 5656

Tony Quirke / Stefano Aquilino (Sales and Corporate Broking)

Notes to Editors:

About CAP-XX

CAP-XX (LSE: CPX) is a leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high-power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics and deliver similar benefits in automotive and other transportation applications.

For more information about CAP-XX, visit www.cap-xx.com

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.